ストックスクリーナーアプリを入手
7.93
0.51%
0.04
Puma Biotechnology Inc (PBYI) 最新ニュース
Puma Biotechnology Inc (PBYI) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Puma Biotechnology Inc (PBYI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Puma Biotechnology Inc (PBYI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Puma Biotechnology Inc (PBYI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
ETFs Investing in Puma Biotechnology, Inc. Stocks - TradingView
PBYI|Puma Biotechnology Inc|Price:7.980|Chg%:-0.030 - TradingKey
Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2026 Financial Results - WBOC TV
Puma Biotechnology schedules conference call on Q2 2026 results - Bitget
Puma Stock Puma Biotechnology Inc Discount Puma Biotechnology Acquisition Outlet Online PUMA Biotechnology Form S - มูลนิธิเพื่อผู้บริโภค มพบ.
Puma Biotechnology’s Douglas M. Hunt sells $69,904 in shares By Investing.com - Investing.com Nigeria
Puma biotechnology CFO Maximo Nougues sells $77,556 in stock By Investing.com - Investing.com South Africa
Form 4 Puma Biotechnology Inc For: 8 July By Investing.com - Investing.com Nigeria
Alan Auerbach, Puma Biotechnology president and CEO, sells $364,051 By Investing.com - Investing.com South Africa
Puma Biotechnology (PBYI) CEO sells 44,058 shares under 10b5-1 plan - Stock Titan
Puma Biotechnology (PBYI) CFO sells 9,386 shares in 10b5-1 trade - Stock Titan
Alan Auerbach, Puma Biotechnology president and CEO, sells $364,051 - Investing.com
Form 144 PUMA BIOTECHNOLOGY For: 6 July By Investing.com - Investing.com Nigeria
[144] PUMA BIOTECHNOLOGY, INC. SEC Filing - Stock Titan
Price to sales forward of Puma Biotechnology Inc – NASDAQ:PBYI - TradingView
PBYIPuma Biotechnology Inc Latest SEC Filings - Finviz
Puma Biotechnology highlights targeted cancer therapies as investors watch Nasdaq-listed PBYI - Ad-hoc-news.de
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)July 2, 2026 - BioSpace
PBYI News | PUMA BIOTECHNOLOGY INC (NASDAQ:PBYI) - ChartMill
Puma Biotechnology awards stock to four new employees - Stock Titan
Puma Biotechnology, Inc.(NasdaqGS:PBYI) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
Puma Biotechnology, Inc.(NasdaqGS: PBYI) added to Russell 2500 Growth Benchmark - marketscreener.com
Puma Biotechnology, Inc.(NasdaqGS: PBYI) added to Russell 2000 Growth Benchmark - marketscreener.com
Puma Biotechnology, Inc.(NasdaqGS: PBYI) added to Russell 3000E Growth Benchmark - marketscreener.com
Puma Biotechnology, Inc.(NasdaqGS:PBYI) added to Russell Microcap Growth Benchmark Index - marketscreener.com
Enterprise value to revenue forward of Puma Biotechnology Inc – BOATS:PBYI - TradingView
Enterprise value to EBITDA forward of Puma Biotechnology Inc – NASDAQ:PBYI - TradingView
PBYI Forecast — Price Target — Prediction for 2027 - TradingView
Price to book forward of Puma Biotechnology Inc – NASDAQ:PBYI - TradingView
Puma Biotechnology, Inc.(NasdaqGS: PBYI) added to Russell 3000 Growth Benchmark - marketscreener.com
Price to sales forward of Puma Biotechnology Inc – BOATS:PBYI - TradingView
Enterprise value to EBIT forward of Puma Biotechnology Inc – BOATS:PBYI - TradingView
Enterprise value to EBITDA forward of Puma Biotechnology Inc – BOATS:PBYI - TradingView
Puma Biotechnology, Inc. Actuals & Estimates (NASDAQ:PBYI) - TradingView
Why Did Puma Biotechnology's Stock Plummet Despite Beating Q4 Estimates - Kavout | AI
Puma Pharmaceuticals Puma Biotechnology Puma Biotechnology Puma 2019 Revenue Breast Cancer Treatment - consumerthai
Puma Biotechnology Inc (PBYI) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Puma Biotechnology Inc (PBYI) Institutional Confidence - TradingKey
PBYI SEC FilingsPuma Biotechnology Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Puma Pharmaceuticals Clinical Trials Puma Biotechnology Mountain Lion Puma Concolor Lounging By Gerry Ellis - consumerthai
Puma Biotechnology Inc (PBYI) Valuation: PE, PB & Fair Value Analysis - TradingKey
Puma Biotechnology Inc (PBYI) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Puma Biotechnology Inc (PBYI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Puma Biotechnology StockShareholders back board but reject warrant extension - AD HOC NEWS
Puma Biotechnology shareholders elect directors and vote on key proposals - Investing.com UK
Puma Biotechnology shareholders elect directors and vote on key proposals By Investing.com - Investing.com South Africa
Puma Biotechnology Shareholders Back Governance, Reject Warrant Extension - TipRanks
Puma Biotechnology (PBYI) investors reelect full board but vote down one proposal - Stock Titan
Puma Biotechnology director Jay Moyes sells $158k in stock By Investing.com - Investing.com India
Puma Biotechnology director Jay Moyes sells $158k in stock - Investing.com UK
Puma Biotechnology director Adrian Senderowicz sells $194,310 in stock - Investing.com UK
2.44%
0.02%
大文字化:
|
ボリューム (24 時間):